Last Posted: Aug 01, 2019
- BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants.
Concolino Paola et al. International journal of molecular sciences 2019 Jul 20(14) - Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
Bercow Alexandra S et al. Journal of surgical oncology 2019 Jul - Somatic variants of potential clinical significance in the tumors of BRCA phenocopies.
Buckingham Lela et al. Hereditary cancer in clinical practice 2019 1721 - Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutations.
Ademuyiwa Foluso O et al. Breast cancer research and treatment 2019 Jul - Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan.
Hung Fei-Hung et al. Scientific reports 2019 Jul 9(1) 10229 - Infographic: “What Every Young Woman Needs to Know About Hereditary Breast and Ovarian Cancer”
CDC, 2019 - [Genetic analysis of Japanese patients with Fanconi anemia: novel findings].
Mori Minako et al. [Rinsho ketsueki] The Japanese journal of clinical hematology 2019 60(6) 691-701 - [Hereditary Breast and Ovarian Cancer Syndrome].
Inuzuka Mayuko et al. Gan to kagaku ryoho. Cancer & chemotherapy 2019 Jul 46(7) 1109-1113 - The 2019 HBOC and Lynch Syndrome Family Day
Michigan Public Health Institute, Register for event, September 21, 2019 - Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
Wood Marie E et al. The breast journal 2019 Jul 25(4) 575-577
.png)
No hay comentarios:
Publicar un comentario